カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の血漿製剤市場2022年：免疫グロブリン、アルブミン、凝固因子、その他

◆英語タイトル：Global Plasma Derived Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8938 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：77 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥501,120	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥751,680	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,002,240	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

血漿製剤とは、ヒトの血漿から製造される医薬品の一種であり、主に免疫グロブリンや凝固因子などの重要な成分を抽出し、治療に利用するものです。血漿は血液中に含まれる液体成分で、タンパク質、電解質、ホルモン、栄養素など多くの生理活性物質を含んでいます。これらの成分は、血漿を提供するドナーから得られ、特定の疾患に対する治療に活用されます。

血漿製剤の特徴は、まずその起源にあります。ヒトの血漿から抽出されるため、生体由来の成分であることが強調されます。これにより、特定の疾患に対して非常に高い特異性と効果を持つことがあります。さらに、血漿製剤はその性質上、他の化学合成薬とは異なり、複雑な成分から構成されているため、作用メカニズムが多様であり、単一の薬剤では治療できないような病状にも対応可能です。

血漿製剤にはいくつかの種類があります。最も知られているものの一つが免疫グロブリン製剤です。これは、免疫系を強化するために使用され、特に免疫不全症や自己免疫疾患、あるいは感染症の治療に役立ちます。免疫グロブリン製剤は、感染症に対する抗体を提供し、感染症の予防や治療に用いられます。

また、凝固因子製剤も重要です。これは、血友病などの凝固異常に悩む患者に対する治療に使用されます。具体的には、血友病Aに対する因子VIIIや、血友病Bに対する因子IXなどが代表的です。これらの製剤は、出血の予防や治療を行い、患者の生活の質を向上させることを目的としています。

加えて、アルブミン製剤も重要です。アルブミンは血漿中に最も多く含まれるタンパク質であり、血漿の浸透圧を維持する役割があります。アルブミン製剤は、重篤なやけど、手術、肝疾患、腎疾患、ショックなどの多くの病状において利用されます。アルブミンの補充により、患者の体液のバランスを整えることが可能となります。

血漿製剤の用途は広範囲にわたり、さまざまな病状への対応が可能です。免疫グロブリン製剤は、風邪やインフルエンザなどの一般的な感染症から、重篤な細菌感染、ウイルス感染に至るまで、幅広い範囲で使用されます。特に、免疫不全の患者にとっては、感染症に対する抵抗力を高める助けとなります。また、自己免疫疾患の治療にも用いられ、これにより免疫系の過剰な反応を抑えることができます。

凝固因子製剤は、血友病の患者にとって命綱となるものです。血友病は遺伝性の疾患であり、凝固因子の欠乏により出血しやすくなる病気です。これらの製剤が利用されることで、患者は通常の生活を送りやすくなります。定期的な投与により、出血のリスクを低減し、重篤な合併症を防ぐことが可能です。

アルブミン製剤は、主に敗血症や外科手術後の体液補充、肝硬変による浮腫の治療などに用いられます。これにより、血液量の改善とともに、さまざまな生理機能の正常化が期待されます。

血漿製剤の製造は高い技術力を要します。血漿は提供された後、厳密な検査を受け、その後、分画・精製されます。このプロセスには、遠心分離、フラグメンテーション、沈殿、ろ過などが含まれており、特定の機能を持つ成分が抽出されます。この工程は非常に重要であり、製剤の効果や安全性に直結します。

また、製品の安全性を確保するため、血漿製剤には様々なウイルス不活化技術が応用されています。これにより、感染症のリスクを軽減し、安全な治療が提供できるように努めています。例えば、加熱処理や化学薬品を用いた処理が行われ、ウイルスを不活性化します。このように、高度な技術によって血漿製剤は安全に使用されるのです。

最近では、再生医療や遺伝子治療の分野でも血漿製剤が注目されています。特に、細胞・遺伝子治療の前処置として、患者の血漿を利用した血漿成分の採取が行われ、その後の治療に活用されることが増えてきています。高い治療効果を持つこれらの新しいアプローチは、今後の医療の進展に大きく寄与するものと期待されています。

日本における血漿製剤の供給は、厳密に管理されており、製品の品質と安全性を確保するための制度が整備されています。製剤の生産は、公的な血液センターや民間企業によって行われ、供給量の確保や新たな治療法の開発が進められています。血漿製剤の需要は高まる一方で、供給の安定性を確保することが課題となっています。そのため、ドナーの確保や、血漿提供に対する理解の促進が非常に重要です。

血漿製剤は、今後も医療の中で重要な役割を果たしていくことでしょう。患者のニーズに応えるため、新たな製剤の開発や技術革新が続けられ、より安全で効果的な治療が提供されることが期待されます。また、世界的な健康問題に対しても、より多くの患者が血漿製剤の恩恵を受けることができるよう、国際的な協力も進められていくことが求められます。

血漿製剤は、生体由来の重要な医薬品であり、多くの患者にとって欠かすことのできない治療手段です。その製造に関わる全てのプロセスが厳重に管理され、患者に信頼性の高い治療を提供することが、今後の医療全体の質を向上させることにつながると信じています。

血漿製剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の血漿製剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

血漿製剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・免疫グロブリン、アルブミン、凝固因子、その他

用途別セグメントは次のように区分されます。
・病院、専門クリニック、外来外科センター、診断センター、その他

世界の血漿製剤市場の主要な市場プレーヤーは以下のとおりです。
・Grifols, S.A.、Octapharma、Antares Pharma、CSL Limited

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、血漿製剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な血漿製剤メーカーの企業概要、2019年～2022年までの血漿製剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な血漿製剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別血漿製剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの血漿製剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での血漿製剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および血漿製剤の産業チェーンを掲載しています。
・第13、14、15章では、血漿製剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Grifols, S.A.、Octapharma、Antares Pharma、CSL Limited
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：免疫グロブリン、アルブミン、凝固因子、その他
・用途別分析2017年-2028年：病院、専門クリニック、外来外科センター、診断センター、その他
・血漿製剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・血漿製剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・血漿製剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・血漿製剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・血漿製剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Plasma Derived Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Plasma Derived Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Plasma Derived Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunoglobulins segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Plasma Derived Drugs include Grifols, S.A., Octapharma, Antares Pharma, CSL Limited, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Plasma Derived Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunoglobulins
Albumins
Clotting Factors
Others
Market segment by Application can be divided into
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Others
The key market players for global Plasma Derived Drugs market are listed below:
Grifols, S.A.
Octapharma
Antares Pharma
CSL Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma Derived Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Plasma Derived Drugs, with price, sales, revenue and global market share of Plasma Derived Drugs from 2019 to 2022.
Chapter 3, the Plasma Derived Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Derived Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Plasma Derived Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma Derived Drugs.
Chapter 13, 14, and 15, to describe Plasma Derived Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Plasma Derived Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plasma Derived Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Immunoglobulins
1.2.3 Albumins
1.2.4 Clotting Factors
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Plasma Derived Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Global Plasma Derived Drugs Market Size & Forecast
1.4.1 Global Plasma Derived Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Plasma Derived Drugs Sales in Volume (2017-2028)
1.4.3 Global Plasma Derived Drugs Price (2017-2028)
1.5 Global Plasma Derived Drugs Production Capacity Analysis
1.5.1 Global Plasma Derived Drugs Total Production Capacity (2017-2028)
1.5.2 Global Plasma Derived Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Plasma Derived Drugs Market Drivers
1.6.2 Plasma Derived Drugs Market Restraints
1.6.3 Plasma Derived Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Grifols, S.A.
2.1.1 Grifols, S.A. Details
2.1.2 Grifols, S.A. Major Business
2.1.3 Grifols, S.A. Plasma Derived Drugs Product and Services
2.1.4 Grifols, S.A. Plasma Derived Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Octapharma
2.2.1 Octapharma Details
2.2.2 Octapharma Major Business
2.2.3 Octapharma Plasma Derived Drugs Product and Services
2.2.4 Octapharma Plasma Derived Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Antares Pharma
2.3.1 Antares Pharma Details
2.3.2 Antares Pharma Major Business
2.3.3 Antares Pharma Plasma Derived Drugs Product and Services
2.3.4 Antares Pharma Plasma Derived Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CSL Limited
2.4.1 CSL Limited Details
2.4.2 CSL Limited Major Business
2.4.3 CSL Limited Plasma Derived Drugs Product and Services
2.4.4 CSL Limited Plasma Derived Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Plasma Derived Drugs Breakdown Data by Manufacturer
3.1 Global Plasma Derived Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Plasma Derived Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Plasma Derived Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma Derived Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Plasma Derived Drugs Manufacturer Market Share in 2021
3.5 Global Plasma Derived Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Plasma Derived Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Plasma Derived Drugs Market Size by Region
4.1.1 Global Plasma Derived Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Plasma Derived Drugs Revenue by Region (2017-2028)
4.2 North America Plasma Derived Drugs Revenue (2017-2028)
4.3 Europe Plasma Derived Drugs Revenue (2017-2028)
4.4 Asia-Pacific Plasma Derived Drugs Revenue (2017-2028)
4.5 South America Plasma Derived Drugs Revenue (2017-2028)
4.6 Middle East and Africa Plasma Derived Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Plasma Derived Drugs Sales in Volume by Type (2017-2028)
5.2 Global Plasma Derived Drugs Revenue by Type (2017-2028)
5.3 Global Plasma Derived Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Plasma Derived Drugs Sales in Volume by Application (2017-2028)
6.2 Global Plasma Derived Drugs Revenue by Application (2017-2028)
6.3 Global Plasma Derived Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Plasma Derived Drugs Sales by Type (2017-2028)
7.2 North America Plasma Derived Drugs Sales by Application (2017-2028)
7.3 North America Plasma Derived Drugs Market Size by Country
7.3.1 North America Plasma Derived Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Plasma Derived Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Plasma Derived Drugs Sales by Type (2017-2028)
8.2 Europe Plasma Derived Drugs Sales by Application (2017-2028)
8.3 Europe Plasma Derived Drugs Market Size by Country
8.3.1 Europe Plasma Derived Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Plasma Derived Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Plasma Derived Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Plasma Derived Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Plasma Derived Drugs Market Size by Region
9.3.1 Asia-Pacific Plasma Derived Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Plasma Derived Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Plasma Derived Drugs Sales by Type (2017-2028)
10.2 South America Plasma Derived Drugs Sales by Application (2017-2028)
10.3 South America Plasma Derived Drugs Market Size by Country
10.3.1 South America Plasma Derived Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Plasma Derived Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Plasma Derived Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Plasma Derived Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Plasma Derived Drugs Market Size by Country
11.3.1 Middle East & Africa Plasma Derived Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Plasma Derived Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Plasma Derived Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Plasma Derived Drugs
12.3 Plasma Derived Drugs Production Process
12.4 Plasma Derived Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Plasma Derived Drugs Typical Distributors
13.3 Plasma Derived Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Plasma Derived Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Plasma Derived Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Grifols, S.A. Basic Information, Manufacturing Base and Competitors
Table 4. Grifols, S.A. Major Business
Table 5. Grifols, S.A. Plasma Derived Drugs Product and Services
Table 6. Grifols, S.A. Plasma Derived Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Octapharma Basic Information, Manufacturing Base and Competitors
Table 8. Octapharma Major Business
Table 9. Octapharma Plasma Derived Drugs Product and Services
Table 10. Octapharma Plasma Derived Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Antares Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Antares Pharma Major Business
Table 13. Antares Pharma Plasma Derived Drugs Product and Services
Table 14. Antares Pharma Plasma Derived Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 16. CSL Limited Major Business
Table 17. CSL Limited Plasma Derived Drugs Product and Services
Table 18. CSL Limited Plasma Derived Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Plasma Derived Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Plasma Derived Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Plasma Derived Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Plasma Derived Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Plasma Derived Drugs Production Site of Key Manufacturer
Table 24. Plasma Derived Drugs New Entrant and Capacity Expansion Plans
Table 25. Plasma Derived Drugs Mergers & Acquisitions in the Past Five Years
Table 26. Global Plasma Derived Drugs Sales by Region (2017-2022) & (K Units)
Table 27. Global Plasma Derived Drugs Sales by Region (2023-2028) & (K Units)
Table 28. Global Plasma Derived Drugs Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Plasma Derived Drugs Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 31. Global Plasma Derived Drugs Sales by Type (2023-2028) & (K Units)
Table 32. Global Plasma Derived Drugs Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Plasma Derived Drugs Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Plasma Derived Drugs Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Plasma Derived Drugs Price by Type (2023-2028) & (US$/Unit)
Table 36. Global Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 37. Global Plasma Derived Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Global Plasma Derived Drugs Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Plasma Derived Drugs Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Plasma Derived Drugs Price by Application (2017-2022) & (US$/Unit)
Table 41. Global Plasma Derived Drugs Price by Application (2023-2028) & (US$/Unit)
Table 42. North America Plasma Derived Drugs Sales by Country (2017-2022) & (K Units)
Table 43. North America Plasma Derived Drugs Sales by Country (2023-2028) & (K Units)
Table 44. North America Plasma Derived Drugs Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Plasma Derived Drugs Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 47. North America Plasma Derived Drugs Sales by Type (2023-2028) & (K Units)
Table 48. North America Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 49. North America Plasma Derived Drugs Sales by Application (2023-2028) & (K Units)
Table 50. Europe Plasma Derived Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Plasma Derived Drugs Sales by Country (2023-2028) & (K Units)
Table 52. Europe Plasma Derived Drugs Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Plasma Derived Drugs Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Plasma Derived Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Europe Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Plasma Derived Drugs Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Plasma Derived Drugs Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Plasma Derived Drugs Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Plasma Derived Drugs Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Plasma Derived Drugs Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Plasma Derived Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Plasma Derived Drugs Sales by Application (2023-2028) & (K Units)
Table 66. South America Plasma Derived Drugs Sales by Country (2017-2022) & (K Units)
Table 67. South America Plasma Derived Drugs Sales by Country (2023-2028) & (K Units)
Table 68. South America Plasma Derived Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Plasma Derived Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 71. South America Plasma Derived Drugs Sales by Type (2023-2028) & (K Units)
Table 72. South America Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 73. South America Plasma Derived Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Plasma Derived Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Plasma Derived Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Plasma Derived Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Plasma Derived Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Plasma Derived Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Plasma Derived Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Plasma Derived Drugs Raw Material
Table 83. Key Manufacturers of Plasma Derived Drugs Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Plasma Derived Drugs Typical Distributors
Table 87. Plasma Derived Drugs Typical Customers
List of Figures
Figure 1. Plasma Derived Drugs Picture
Figure 2. Global Plasma Derived Drugs Revenue Market Share by Type in 2021
Figure 3. Immunoglobulins
Figure 4. Albumins
Figure 5. Clotting Factors
Figure 6. Others
Figure 7. Global Plasma Derived Drugs Revenue Market Share by Application in 2021
Figure 8. Hospitals
Figure 9. Speciality Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Diagnostic Centers
Figure 12. Others
Figure 13. Global Plasma Derived Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Plasma Derived Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Plasma Derived Drugs Sales (2017-2028) & (K Units)
Figure 16. Global Plasma Derived Drugs Price (2017-2028) & (US$/Unit)
Figure 17. Global Plasma Derived Drugs Production Capacity (2017-2028) & (K Units)
Figure 18. Global Plasma Derived Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Plasma Derived Drugs Market Drivers
Figure 20. Plasma Derived Drugs Market Restraints
Figure 21. Plasma Derived Drugs Market Trends
Figure 22. Global Plasma Derived Drugs Sales Market Share by Manufacturer in 2021
Figure 23. Global Plasma Derived Drugs Revenue Market Share by Manufacturer in 2021
Figure 24. Plasma Derived Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Plasma Derived Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Plasma Derived Drugs Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Plasma Derived Drugs Sales Market Share by Region (2017-2028)
Figure 28. Global Plasma Derived Drugs Revenue Market Share by Region (2017-2028)
Figure 29. North America Plasma Derived Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Europe Plasma Derived Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Plasma Derived Drugs Revenue (2017-2028) & (USD Million)
Figure 32. South America Plasma Derived Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Plasma Derived Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Global Plasma Derived Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global Plasma Derived Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global Plasma Derived Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 37. Global Plasma Derived Drugs Sales Market Share by Application (2017-2028)
Figure 38. Global Plasma Derived Drugs Revenue Market Share by Application (2017-2028)
Figure 39. Global Plasma Derived Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America Plasma Derived Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America Plasma Derived Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Plasma Derived Drugs Sales Market Share by Country (2017-2028)
Figure 43. North America Plasma Derived Drugs Revenue Market Share by Country (2017-2028)
Figure 44. United States Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Plasma Derived Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Plasma Derived Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Plasma Derived Drugs Sales Market Share by Country (2017-2028)
Figure 50. Europe Plasma Derived Drugs Revenue Market Share by Country (2017-2028)
Figure 51. Germany Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Plasma Derived Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Plasma Derived Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Plasma Derived Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Plasma Derived Drugs Revenue Market Share by Region (2017-2028)
Figure 60. China Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Plasma Derived Drugs Sales Market Share by Type (2017-2028)
Figure 67. South America Plasma Derived Drugs Sales Market Share by Application (2017-2028)
Figure 68. South America Plasma Derived Drugs Sales Market Share by Country (2017-2028)
Figure 69. South America Plasma Derived Drugs Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Plasma Derived Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Plasma Derived Drugs Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Plasma Derived Drugs Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Plasma Derived Drugs Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Plasma Derived Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Plasma Derived Drugs in 2021
Figure 81. Manufacturing Process Analysis of Plasma Derived Drugs
Figure 82. Plasma Derived Drugs Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の血漿製剤市場2022年：免疫グロブリン、アルブミン、凝固因子、その他(Global Plasma Derived Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の血漿製剤市場2022年：免疫グロブリン、アルブミン、凝固因子、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp